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ABSTRACT 
 
Luminescenct Quantum Dots (QDs) intrigue the interest of researchers with their properties of 
high quantum yield, broad absorption and narrow emission spectra. Since prepared in organic 
solvents, QDs are not suitable for biological systems. In my study, several methods of “cap 
exchange” were tested to enable forming water – soluble QDs with minimal aggregation .The 
QD-mercaptoacetic acid is simple to synthesize and has good water-solubility, but the QDs are 
not stable. The direct attachment of peptide molecules to the QDs can passivate the surface and 
enable water solubility of QDs. It is only applicable for phytochelatin – related peptides, not for 
all kind of peptides. The co-coupling peptide and PEG on QDs, has good water –solubility when 
the quantity of PEG and coupling agent EDAC are controlled. The enzymatic activities based on 
QDs FRET system at different environments was demonstrated and the results show that pH 
affect the enzymatic activity significantly. 
 1 
CHAPTER 1 INTRODUCTION AND BACKGROUND 
 
1.1 Objectives and Aims  
The main goal of my work was to improve the methods of synthesis of water – soluble 
quantum dots (QDs), which prevent aggregation when applying QDs in biological system. The 
water – soluble QDs were used to test the effect of pH on FRET between QDs and Rhodamine 
using enzyme – based assay.  
1.2 Significance and Impact 
QDs are semiconducting materials generally synthesized with II-VI or III-V column elements 
of the periodic table. Due to their high photostability, high emission quantum yield, narrow 
emission peaks and size-dependent wavelength tunability, these luminescent nanoparticles have 
been seen as alternative labels to organic fluorophores. QDs have great potential as biological 
probes for vivo imaging of living cells and diagnostics1.  
Since usually synthesized with high – temperature routes in organic solvents, QDs have no 
aqueous solubility. Aqueous solubility is imperative for the application in biological systems2. 
The first part of my work was to test different ways to synthesize water – soluble QDs and 
compare their aqueous solubility and luminescence properties.  
Fluorescence resonance energy transfer (FRET) is an important signal transduction technique 
in optical biosensor. It is powerful in probing sub-nanometer scale changes in the separation 
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distance between donor and acceptor fluorophores, which is ideal for the sensitive detection of 
molecular binding events and changes in protein conformation in response to interaction with a 
particular target molecule or to changes in the solution environment.  
   A crucial aspect of FRET biosensor is the development of optimized donor and acceptor dyes 
to function in concert with desired recognition elements. Recently, hydrophilic QDs like CdSe-
ZnS core-shell nanocrystals have been demonstrated as excellent FRET donors with proximal 
organic dyes. FRET – based QD biosensor was recently developed in our laboratory for the 
measurement of the activity of digestive enzyme. FRET-based QD-biosensors could permeate 
into cells and monitor intracellular processes potentially in real – time. The second part of my 
work was to investigate the effect of pH to the FRET – based QD biosensor system developed in 
our laboratory. 
1.3 Fluorescence Principle 
1.3.1 Jabloński Diagram 
  Light absorption and emission and different molecular processes occurring in the excited 
states during fluorescence are often shown in the Jabloński Diagrams. In a typical Jabloński 
Diagram shown in Fig. 1.1, S
0, S1 and S2 show the singlet ground state, first and second excited 
states respectively. T
1 
is the first triplet state. The light absorbed by a fluorophore excites an 
electron from the singlet ground state to S1 or S2 according to the magnitude of the absorbed 
energy. This process happens very fast within 10-15 s.  Then in the next 10 -12s, internal 
conversion usually occurs when the excited fluorophore molecules relax to the lowest vibrational 
level of S1.Since emission typically happens after 10-9s, the molecule can be fully relaxed at the 
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time of emission, so emission occurs from the lowest vibrational level of S1 and the fluorescence 
spectrum is generally independent of the excitation wavelength. The absorption and emission 
spectra are the mirror images of each other because the electrons excited do not change the 
nuclear geometry. The process of intersystem crossing occurs when the electrons in the first 
excited state S
1 
transit to the triplet state T
1
. This process will emit phosphorescence which is 
lower in energy compared to fluorescence3.  
 
Figure 1.1 Jabloński diagram describing different molecular processes occurring in the excited states 
during fluorescence. Legend:  S0, S1 and S2 - singlet ground state, first and second excited states; T1 -  the 
first triplet state. 
 
1.3.2 Fluorescence Resonance Energy Transfer  
Fluorescence resonance energy transfer (FRET) is a distance-dependent interaction between 
the electronic excited states of two dye molecules in which excitation is transferred from a donor 
molecule to an acceptor molecule without emission of a photon. In FRET, light energy, which is 
S2 
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added at the excitation frequency for the donor fluorophore, transfers some of energy to the 
acceptor. Then the acceptor re-emits the light at its own emission wavelength. The net result is 
that since some of the energy gets transferred to the acceptor, the donor emits less energy than it 
normally would; while the acceptor emits more light energy at its emission frequency. As a result, 
the fluorescence intensity and lifetime of donor is decreased and shorten, while the acceptor 
fluorescence is sensitized and its lifetime is longer.  
Wavelength
b.Donor
Emission
d. Acceptor
Emission
a. Donor
Absorption
Spectral overlap
c. Acceptor
Absorption
Flu
ore
scen ce
Inte
n sity
 
Figure 1.2 Spectral overlap (Marked in red color) between the emission spectrum of the donor and the 
absorption spectrum of the acceptor.  a,b – absorption and emission of donor; c,d – absorption and 
emission of acceptor.  
 
   There are three primary conditions for FRET donor/acceptor pairs: 1) the donor and acceptor 
molecules must be in close proximity (typically 10-100 Å); 2) The absorption spectrum of the 
acceptor must overlap with the fluorescence emission spectrum of the donor (Fig. 1.2); 3) Donor 
and acceptor transition dipole orientations must be approximately parallel4. The efficiency of 
energy transfer is dependent on the extent of spectral overlap between the emission spectrum of 
the donor and the absorption spectrum of the acceptor, the relative orientation of donor/acceptor 
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transition dipoles and the distance between the donor and acceptor. FRET is an important 
technique for investigating a variety of biological phenomena that produce changes in molecular 
proximity. FRET based sensing assemblies have been used successfully in biological 
applications including studying protein-protein interactions (binding affinity), protein 
conformational changes.5, 6 
1.4 Characteristics of QDs 
Semiconductor nanocrystals can be described as a state of matter intermediate between 
molecular and bulk crystalline. Quantum Dots (QDs) are semiconductors with radii of 1-10 nm, 
i.e., smaller than the bulk Bohr radius of photoexcited electron-hole pairs in semiconductors (~1-
10nm). From quantum mechanical point of view, when the radii of the QDs are smaller than the 
bulk Bohr excitation radius, the energy bands will be divided into energy levels under the 
quantum confinement.  The small size and high optical activity of semiconductor nanocrystals 
make them a very interesting material for chemist, physicists, engineers and biologists who are 
collaborating to study these materials and exploit their properties in many different applications7. 
1.4.1 Structural Properties of QDs 
In the same way that bulk semiconductors are characterized by the structure of their conduction 
and valence bands as being direct or indirect, so are semiconductor nanocrystals. Direct 
semiconductor nanocrystals (e.g. CdSe, CdS) are characterized by having the minimum 
transition energy to promote an electron from the valence band to the conduction band without a 
change in the electron momentum. The energy of this energy separation is known as the band-
gap shown in Fig 1.318. For indirect semiconductors, however, excitation at the band gap energy 
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must be accompanied by a change in the electron’s momentum, which is supplied by a photon9, 10. 
  Although both types of semiconductors are efficient absorbers of light, only direct 
semiconductors are emissive enough to be used as an optical source or as fluorescent labels 
(CdSe). The size of the crystal is less than the excitation’s Bohr radius. For Si this is 49Å and for 
CdSe it is 61 Å. Crystallites with diameters smaller than the excitation’s Bohr radius are said to 
be in the Quantum Confined (QC) regime. Quantum confinement has two main consequences: 1) 
it causes a blue shift in the band gap energy as shown in figure 1.4; 2) it increases the probability 
of overlap between the electron and hole which increases the rate of radiative recombination11-12.  
S
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Figure 1.3 Energy level diagram comparing a silicon atom (left), molecular analog (middle) and bulk 
semiconductor (right). Orbital hybridization leads to the formation of bands and the existence of a band-
gap. σ, σ* - bonding and antibonding molecular orbitals; Eg – bandgap in the bulk semiconductor. 
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Figure 1.4 blue-shift in the bandgap energy in nm sized geometries with respect to the bulk crystal. Egap - 
bandgap energy in bulk crystal; Econfinement  - blue shift in the band gap energy due to quantum confinement.  
          
1.4.2 Optical Properties of QDs 
     QDs have several characteristic which distinguish them from conventional organic 
fluorophores. QDs have different band gap energies with different sizes, so light absorption is a 
function of size. Since the size and shape of QDs can be precisely controlled by the duration, 
temperature, and ligand molecules used in their syntheses, QDs show composition- and size-
dependent absorption and emission properties. QDs can be synthesized with various types of 
semiconductor materials (II-VI: CdS, CdSe, CdTe…; III-V: InP, InAs…; IV-VI: PbSe) 
characterized by different bulk band gap energies.  
   The creation of an electron - hole pair (i.e., excitation) is a result of absorption of a photon 
with energy above the semiconductor band gap energy. The probability of absorption increases 
with higher energies, which result in a broadband absorption spectrum. The radiative 
recombination of an excitation leads to the emission of a photon in a narrow, symmetric energy 
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band, so the emission spectra of QDs is fairly narrow as the full width at half-maximum intensity 
is usually in the range of  20 to 40nm. 
  For organic fluorophores such as genetically encoded fluorescent proteins or chemically 
synthesized fluorescent dyes, each fluorophore can only be excited optimally by the light of 
defined wavelength, which makes it hard to use single excitation sources for multicolor 
application. Also, organic fluorophore usually have wide emission spectra that tend to spread out 
more towards the red region called ‘red tail’.    
   For chemists, the most popular QD materials are CdSe and CdS. The absorption onsets are ~ 
720 nm and ~ 520 nm for CdSe and CdS respectively, so their absorption energies can be 
adjusted through the visible region. Therefore CdSe QDs have visible absorption spectra with 
wavelengths ranging from the red to the violet. The smaller is the size, the shorter the emission 
wavelength.  
   Depending on the particle size and the excitation wavelength, the molar extinction 
coefficients of CdSe QDs are estimated as ~105 – 106 M-1cm-1, which is 10-100 times larger than 
those of organic dyes. The superior performance in terms of  the emission lifetime for QDs 
compared with commonly used organic dyes has been demonstrated already13, 14.  
1.5 Synthesis and Capping Strategies of QDs 
 QDs can be synthesized in different media such as in aqueous solution 15, reverse micelles16, 
polymer films 17, 18, sol-gel systems19 and solvents/ligands 20-23, among which the synthesis in 
Solvents/ligands such as trioctyl phosphine (TOP) / trioctyl phosphine oxide (TOPO) is used 
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widely. The size and shape of QDs are tunable by altering the duration, temperature, and ligand 
molecules.  
 To get QDs with bright luminescence, it is imperative to confine the electrons to the bulk of 
luminescent QDs. However, surface defects are still formed even under the best reaction 
conditions. Due to these surface defects, it is possible for electrons to leak from the bulk of the 
nanocrystals to the surface defects, which results in poor photoluminescence. Additionally, the 
presence of surface defects broadens the luminescence peaks of QDs24. To alleviate the effect of 
surface defects and  protect surface atoms from oxidation and other chemical reactions, a process 
called surface passivation was reported where an additional thin layer made of a wider band gap 
semiconductor material, for example ZnS, grows on the surface of the QDs 25-29 . This process 
enhances the emission quantum yield and photostablility of luminescent QDs.   
High-quality colloidal QDs can be achieved by using high-temperature growth solvents/ligands 
( mixture of trioctyl phosphine / trioctyl phosphine oxide, TOP/TOPO), combined with pyrolysis 
of organometallic precursors, yielded CdSe QDs with highly crystalline cores and size 
distributions of 8-11%. Then the reaction combined with appropriate organometallic precursors 
is further used to overcoat the native CdSe core with a layer of wider-band gap semiconducting 
material (Fig. 1.8). 
CdSe ZnS
TOP TOPO
Shell Grow thTOP-Se +
TOPO -Cd
Nucleation Grow th
C dSe
 
Fig 1.8 Syntheses of CdSe-ZnS with TOPO 
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  Since Murray20 first reported Pyrolysis of organometallic precursors in TOP/TOPO media in 
1993, this method has been further developed. The significant improvement was reported by 
Peng and coworkers 21-23, who replaced the toxic cadmium precursor Cd(CH3)2  with CdO, 
Cd(Ac)2 and CdCO3. Peng’s method is used extensively for the syntheses of luminescent QDs. 
Quantum dot products are now available commercially (Evident Technologies (NY), QDs 
Corporation (CA)).   
1.6 Synthesis of Water – Soluble QDs 
  With their size-dependent wavelength tunability, narrow and symmetric emission peaks, high 
emission quantum yield and high photostability, luminescent QDs have been proved to be good 
alternatives to commonly used organic fluorophores commonly used in aqueous biological 
systems 30, 34. To apply the QDs in aqueous biological systems, the hydrophobic capping ligands 
of luminescent QDs must be replaced with hydrophilic capping ligands. The phase transfer of 
QDs to aqueous solutions is realized primarily through ‘cap exchange’ or encapsulating the 
original nanocrystals in a thick herterofunctional organic coating. There are three main strategies: 
(1) ‘cap exchange’, a process involving the substitution of the native TOP/TOPO with 
bifunctional ligands, each presenting a surface-anchoring moiety to bind to the inorganic QD 
surface and an opposing hydrophilic end group30-34; (2) formation of polymerized silica shells 
functionalized with polar groups35-36; (3) amphiphilic ‘diblock’ and ‘triblock’ copolymers and 
phospholipids, which interleave the alkylphosphine ligands through hydrophobic attraction, 
whereas the hydrophilic outer block permits aqueous dispersion37-43. 
Each of the three strategies mentioned above has advantages and drawbacks. The compact 
mono – mercapto ligands are simple to synthesize, but are not stable due to the dynamic thiol – 
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ZnS interactions44. Although dithiol dihydrolipoic acid ligands can improve the stability31, 34, 44, 
almost all carboxyl – terminated ligands limit dispersion to basic pHs44.  The 
polymer/phospholipids encapsulation can work over a broader pH range. However since silica 
shells tend to increase the diameter of CdSe-ZnS from ~ 4-8 nm to ~ 20-30nm, a size that may 
preclude fluorescence resonance energy transfer (FRET)-based studies44. Therefore, ‘cap 
exchange’ is the predominant method to prepare water-soluble QDs in FRET – based biological 
applications.  
  The TOPO ligands groups are often exchanged with thiol functionalized compounds like 
mercaptoacetic acid (MMA) 30, dihydrolipoic acid (DHLA) 45, and Dithiothreitol(DTT)46. 
Recently cysteine-containing peptides could also be used as effective capping ligands to facilitate 
the water miscibility of QDs 47, 48. Over the past few years, water-soluble CdSe/ZnS luminescent 
semiconductor QDs have been widely used in immunoassays 49-51, in situ hybridization 52,53, 
cellular imaging 54-56 and in vivo imaging 57,58 studies as luminescent labels.   
1.7 QDs FRET-Based studies 
 Since FRET is sensitive to molecular rearrangements on the 1-10 nm range, a scale correlating 
to the size of biological macromolecules, the papers on QDs as FRET donors in biological 
systems to monitor intracellular interactions and binding events have been reported quickly.  By 
self – assembling acceptor dye – labeled proteins onto Donor surfaces, QDs have two unique 
advantages over organic fluorophores for FRET: the QD donor emission could be size – tunable 
to improve spectral overlap with a particular acceptor dye; several acceptors could interact with a 
single QD donor to improve FRET efficiency. The latter advantage by using a 30 Å radius QD 
with a dye –labeled protein attached to the QD surface and the dye located at 70 Å from the core. 
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Assuming the Förster distance (R0) for this QD donor – dye acceptor pair of 56 Å, the FRET 
efficiency for a single pair would be 22 %. Increasing the number of accepotors to five, the 
efficiency could be ~ 58%3.  
Van Orden and coworkers used CdSe-ZnS QDs as resonance energy transfer donors in a model 
protein – protein and showed that the specific binding of different proteins can be observed via 
FRET between a CdSe-ZnS QD donor attached to one of the protein and in a strong 
enhancement of the dye fluorescence that was well resolved from the QD emission spectrum59. 
Mauro and co-workers have developed FRET-based maltose-binding assays by coating 
CdSe/ZnS QDs capped with DHLA with maltose binding protein (MBP) molecules.  The FRET 
assay was based on the interactions between MBP and the acceptor cyclodextrin CY 3. Maltose 
molecules displace the fluorescent cyclodextrin acceptor molecules, which resulted in a maltose 
concentration dependent increase in the emission of the MBP coated QDs.  Hydrophobic CdSe 
QDs were embedded into lipid membranes as demonstrated with biomimetic vesicles. FRET was 
seen to a lipid – soluble dye (DiD) and water – soluble dye (Cy 3.5) in which the vesicles were 
suspended. The degree of energy transfer to each dye demonstrated that most of QDs are located 
within the lipid60-63.  FRET between streptavidin conjugated QDs and biotinylated gold 
nanoparticles have also been reported by Oh and coworkers64. FRET between QDs and AuNPs 
can be used for assay of a molecule which inhibits the biomolecular interactions.    Goldman et al. 
developed a hybrid QDs antibody fragment FRET based TNT sensor65. Luminescent QDs were 
conjugated to antibody fragments for the specific detection of the explosive 2, 4, 6-
trinitrotoluene (TNT) based on fluorescence resonance energy transfer (FRET) in aqueous 
environments. Drezek and coworkers developed a novel nanoparticulate luminescent probe, in 
which QDs are bound to gold nanoparticles by a proteolytically degradable peptide sequence 
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with FRET66. Releases of gold nanoparticles by peptide cleavage restore radiative QD 
photoluminescence. This probe has great potential in biological applications since its 
customizable peptide linker sequence can monitor a protease of interest.  
1.8 Work Statement  
This thesis will use strategy of ‘cap exchange’, which is simple and quick to prepare 
biocompatible water-soluble QDs. Based on the work of  Desheng Wang and Lifang Shi in our 
lab, the synthesis, and test of the QDs-peptide-Rhodamine FRET system as sensor to enzymatic 
activity, in which luminescent QDs served as energy donor and Rhodamine red as energy 
acceptor are introduced briefly. Then the effect of pH on QDs based FRET system using the 
activity of trypsin is tested.  
The thesis addresses the following:  
1) Synthesis of CdSe –ZnS QDs.  
2) Improvement of water – solubility of QDs using ‘cap exchange’. 
3) Testing of effect of pH on QDs FRET system for measuring the activity of trypsin. 
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CHAPTER 2 EXPERIMENTAL 
 
2.1 Material and Reagents  
Cadmium Oxide (CdO, Sigma); Lauric Acid (Sigma); Trioctylphosphine (TOP, Sigma); 
Trioctylphophine Oxide (TOPO, Sigma); hexadecylamine (HDA, Sigma); Selenium powder 
(Sigma); Diethylzinc (Zn(Et)2, Sigma); Hexamethyldisllathiane ((TMS)2S, Sigma); 
Mercaptoacetic acid (Sigma); Peptide RGDC (American peptide company); Peptide AGSE 
(American peptide company); Tetramethylammonium hydroxide (TAMOH, Sigma); Dimethyl 
sulfoxide (DMSO, Sigma); Methanol(Sigma); Pyridine (Sigma); Trypsin (Sigma); Amicon 
centricon spin dialysis tube (Microcon YM30, Millipore Corp); Rhodamine Red-X, succinimidyl 
ester 5-isomer (Molecular Probes, Inc); LissamineTM  rhodamine B ethylenediamine (Molecular 
Probes, Inc); Glacial mercaptoacetic acid (Aldrich); Phosphate-buffered saline (PBS) solution 
(pH 7.4); mPEG-MAL (Nectar); Chloroform (Sigma). All aqueous solutions were prepared with 
18 MΩ deionized water produced by a water purification system (Barnstead Thermolyne 
nanopure) and all chemicals were used as received without further purification.  
2.2 Optical measurement Instrumentation  
Fluorescence Spectroscopy Measurements - Emission spectra were measured with PTI model 
QM-1 spectrofluorometer (PTI, Quantamaster, Ontario, Canada), equipped with a with a 75-W 
continuous Xe arc lamp as a light source. 
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Digital Fluorescence Microscopy - Luminescence images were obtained with a digital 
luminescence imaging microscopy system. Primarily used instrument in the research work is 
inverted fluorescence microscope (Olympus IX-70) equipped with a 100 W mercury lamp as a 
light source. A 20X microscope objective with NA = 0.9 was used to collect the fluorescence 
images. To ensure spectral imaging purity, a filter cube with a 450 ±10 nm band-pass excitation 
filter, a 505 nm dichroic mirror, and a 515-nm long pass emission filter was used. Digital 
imaging is obtained with a high-performance ICCD camera (Princeton Instruments, model 
BH2RFLT3).  A PC microcomputer was employed for data acquisition and The Roper Scientific 
software WinView/32 was used for image analysis. 
2.3 Synthesis of TOPO Coated CdSe/ZnS QDs 
The trioctylphosphine oxide (TOPO) coated CdSe/ZnS QDs was synthesized based on Wang’s 
method67. All the reactions here were under nitrogen gas. 12.7 mg CdO and 160 mg lauric acid 
were mixed for half an hour under nitrogen gas. The mixture was heated to >220 °C and formed 
a clear colorless solution indicating the fully dissolved cadmium oxide. 1.94 g TOPO and 1.94 g 
hexadecylamine (HDA) were added to the solution while stirring and the temperature was raised 
to ~280 °C. The mixture was cooled to ~220 °C and 80 mg selenium powder in 2ml 
trioctylphosphine (TOP) solution was rapidly injected into the solution under vigorous stirring. 
The temperature was kept at 220℃ for 2 minutes and a solution containing 250 μl 
hexamethyldisllathiane ((TMS)2S) and 1 ml diethylzinc (Zn(Et)2) premixed in 2 ml TOP was 
gradually injected into the solution. The reaction mixture was kept at 180 °C for one hour. The 
solution was cooled to room temperature and the resulting sample of CdSe/ZnS QDs was washed 
three times with methanol and redissolved in chloroform.  
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2.4 Test of QDs FRET-Based Probes in Solution 
Rhodamine Red-X, succinimidyl ester 5-isomer, an amine-reactive dye, can covalently attach 
to peptide.  It can be used as FRET acceptor in an enzymatic activity probe, which has been 
developed in our lab and can be used to test the feasibility of synthesis of water – soluble QDs in 
2.5.  The peptide RGDC coated QDs in PBS 7.4 buffer was first prepared using the method in 
2.5.1. The QDs-peptide-Rhodamine bioconjugates were prepared by mixing 150μl of 4.8μM 
Rhodamine Red-X, succinimidyl ester and 150μl of 0.1μM peptide coated QDs with PBS 7.4 
buffer to 1.5mL, and then incubated at room temperature for 1 hour. The sample was excited at 
445nm.  
2.5 Syntheses of Water – Soluble QDs 
2.5.1 Direct attachment of peptides to QDs surface 
1mL of 1µM TOPO coated CdSe/ZnS QDs were precipitated with methanol and re-dissolved 
in 2ml 9:1(V/V) pyridine:DMSO cosolvent. 200μl 5mg/mL peptide RGDC in DMSO was added 
to the reaction mixture.  The pH was adjusted to 10 by adding tetramethyl ammonium hydroxide 
(TAMOH) 20% (w/v) in methanol) to the reaction mixture. The TAMOH molecules were used 
to form anionic cysteine thiolates to facilitate binding of the peptide to the CdSe/ZnS QDs 
through the cysteine residues. After centrifugation, the peptide coated QDs were washed in the 
DMSO co-solvent.  Finally, the peptide coated QDs were suspended in a phosphate buffer 
solutions (PBS) at pH 7.4. Unbound peptide molecules were removed by two repeated cycles of 
spin dialysis using an amicon centricon spin dialysis tube with a cutoff molecular weight of 
30kDa.  In each spin dialysis cycle the sample was centrifuged at 2000 rpm for 20 minutes and 
 17 
 
washed with the PBS solution.  The peptide coated QDs were kept at 4°C in the PBS 7.4. The 
QDs-peptide-Rhodamine bioconjugates were prepared as described in 2.4. 
2.5.2 QD-Mercaptoacetic Acid 
1ml ~1.0μM colloidal QDs were dissolved in chloroform and were reacted with 5ml μM glacial 
mercaptoacetic acid with vigorous stirring overnight. PBS 7.4 solution was added to this reaction 
mixture at a 1:1 volume ratio. After vigorous shaking and mixing, the chloroform and water 
layers separated spontaneously. The aqueous layer, which contained mercaptoacetic coated QDs, 
was extracted. Excess mercaptoacetic acid was removed by four or more rounds of centrifugation. 
Then 1ml 1.0µM mercaptoacetic coated QDs in PBS 7.4 solution were mixed with 200μl 
5mg/mL peptide RGDC in PBS 7.4 solution using 100mM N-Ethyl-N´-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDAC) as coupling agent. Unbound peptide molecules were 
removed by two repeated cycles of spin dialysis using an amicon centricon spin dialysis tube 
with a cutoff molecular weight of 30kDa. The peptide coated QDs were kept at 4°C in the PBS 
7.4. The QDs-peptide-Rhodamine bioconjugates were prepared as described in 2.4. 
2.5.3 Co-coupling positive peptide and PEG on QDs  
Mercaptoacetic acid – coated QDs in PBS 7.4 solution from QD-TOPO were made with 
method described in 2.5.2. 1ml 1mg/ml PEG with Maleimide (mPEG-MAL) in PBS 7.4 solution 
was directly added to a solution of 1ml ~1.0μM mercaptoacetic acid-coat QDs in PBS buffer 7.4 
and incubated overnight at room temperature. The excess PEG is removed by two repeated 
cycles of spin dialysis using an amicon centricon spin dialysis tube with a cutoff molecular 
weight of 30kDa. Afterward, 200μl 5mg/mL peptide AGSE in PBS 7.4 solution and100mM 
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EDAC were added to the PEG/QDs solution and incubated overnight at room temperature. The 
peptide and PEG co-coated QDs were kept at 4°C in the PBS 7.4. The QDs-peptide-Rhodamine 
bioconjugates were prepared as described in 2.4. Here Rhodamine is LissamineTM rhodamine B 
ethylenediamine, which is a carboxylic-reactive dye.  
2.6 Effect of pH on FRET Using Enzymatic Activity in Enzymatic Assay 
 In this experiment, 500ul of 1 mg/ml trypsin were added to 500ul QDs-peptide-Rhodamine 
bioconjugates in buffer with a total volume of 1mL. The pH of the buffer was 5.6, 7.4 and 8.7. 
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CHAPTER 3 RESULTS AND DISCUSSION 
 
   Our lab developed for the first time QD based enzymatic activity probes, whose schematic 
diagram is showed in figure 3.1.  First, the TOPO ligands on the surface of QDs are exchanged 
with the tetra peptide RGDC, which contains cysteine as effective capping ligands to facilitate 
the water miscibility of QDs.  Then, the peptide coated QDs are labeled with Rhodamine, and 
FRET happens between the QDs (donor) and the Rhodamine molecules (acceptor). But when the 
peptide is cleaved enzymatically, the FRET between the QDs and the Rhodamine molecules is 
diminished.  
CdSe/ZnS Peptide Rhodamine
Excitation
Emiss ion
FRET
Trypsin
Rhodamine
Excitation
Emis s ion
FRET
CdSe/ZnS
 
 
Figure 3.1 Schematic diagram of the principle of QDs based enzymatic activity probes 
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   In my work, different methods were tested to prepare water – soluble QDs by using “cap 
exchange” strategy, which would be helpful in solving the problem of aggregation of the QDs in 
FRET system. Then the effect of pH on the FRET system was tested.  
3.1 TOPO Coated CdSe/ZnS QDs 
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Figure 3.2 Fluorescence emission spectra of the TOPO coated CdSe/ZnS QDs. CdSe/ZnS in Chloroform 
is excited 445nm and fluorescence emission spectra recorded from 450nm to 700nm. 
 
 The Luminescent CdSe/ZnS QDs used for the experiments were synthesized through the 
approaches developed by by Peng and coworkers with minor modifications. The 
photoluminescence (PL) spectrum of the CdSe/ZnS QDs is shown in Fig 2.2. The emission 
wavelength is ~ 550 nm at excitation wavelength of 445nm. The full width at half – maximum 
(fwhm) of the synthesized QDs is 40 ± 2 nm, which is only slightly higher than the one indicated 
in previous literature reports (25-35 nm ) 68.                                                                                                               
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3.2 FRET between QDs and Rhodamine 
 The FRET system between CdSe/ZnS QDs and Rhodamine was constructed. The results from 
repeated experiments (Fig 3.3) fit those obtained previous in our lab. When excited at 445 nm the 
emission spectrum of the Rhodamine labeled QDs show two clearly separated emission peaks of 
the QDs and the Rhodamine molecules at 545 nm and 587 nm respectively.  The emission peak 
of the QDs decreases with increasing Rhodamine concentration indicating the FRET between the 
QDs and the Rhodamine molecules occurs.  
 
450 500 550 600 650 700
0
2000
4000
6000
8000
10000
12000
E
m
is
si
on
 In
te
ns
ity
wavelength(nm)
 a 0:1
 b 16:1
 c 32:1
 d 48:1a
b
c
d
 
 
Figure 3.3 Fluorescence emission spectra of QDs donor and the corresponding Rhodamine dye 
acceptor in QDs- peptide-Rhodamine conjugates as a function of increasing dye to QDs ratio. 
The excitation wavelength is 445nm and fluorescence emission spectra are recorded from 450nm 
to 700nm. 
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3.3 Synthesis of Water – Soluble QDs 
3.3.1 Direct attachment of protein/peptides to QD surface 
 Previously Weiss and co-workers69 demonstrated the direct attachment of peptides to the QDs 
surface using phytochetatin – related peptides to cap CdSe/ZnS core/shell QDs based on the 
naturally formed organic – inorganic hybrid materials. It not only provided surface passivation 
and water solubility, but also a point of biochemical modification. In our lab, the simple peptide 
was used to coat QDs directly. In this study, we used the tetra peptide RGDC to coat CdSe/ZnS 
QDs. To avoid aggregation of QDs during the coating reaction, 9:1 (V/ V) pyridine/DMSO was 
used as cosolvent to dissolve both peptides and the TOPO – coated QDs. Since 
tetramethylammonium hydroxide (TAMOH) has previously been shown to remove TOPO 
effectly from the surface of CdSe/ZnS QDs, the binding of the peptides on the ZnS layer was 
triggered by forming cysteine thiolates anions with addition of TAMOH base. Upon binding of 
the peptide, the QDs precipitated out of the cosolvent, and could be redissolved in water. The 
excess of unbound peptide was then removed by dialysis using an amicon centricon spin dialysis 
tube with a cutoff molecular weight of 30kDa. 
The direct attachment of peptide to molecules of QDs is quick as ~ 1 hour.  It can enable 
linking the QDs to Rhodamine molecules and facilitate FRET interaction between them. The 
emission spectra (figure 3.5) proved the occurrence of FRET between QDs and  Rhodamine. The 
Digital fluorescence microscopy images were also used to provide visual evidence of FRET 
between the QDs and Rhodamine. As shown in Figure 3.6 and 3.7, the emission color of peptide 
coated QDs is green (figure 3.6) and the emission color turns yellow when Rhodamine is bound 
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to the peptide coated QDs (figure 3.7). This emission color indicates the occurrence of FRET 
between QDs and the bound Rhodamine molecule.   
Since the peptide RGDC has a polar but positively charged domain containing arginine residue 
(R), this amino acid was used to provide the sites for enzymatic cleavage;  the QDs readily 
aggregated upon water solubilization. These aggregations could be due to the interaction of the 
positively charged arginine residues with the negatively charged surface of the QDs, the problem 
of aggregation is severe.  
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Figure 3.4 Emission spectra of (a) QD – peptide; (b) QD-peptide-Rhodamine; (c) QD – peptide-
Rhodamine after adding trypsin at excitation wavelength of 445 nm. Here150μl of 0.1 μM peptide coated 
QDs , 150 μl of 4.8 μM Rhodamine Red-X, succinimidyl ester with PBS 7.4 buffer and 500ul of 1mg/ml 
trypsin in total 1ml solution.  
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Figure.3.5 Digital fluorescence image of QD-peptide by direct attachment of peptide RGDC to QD 
surface. The image was taken through an excitation filter: λex=450 nm, a dichroic mirror: 505nm; an 
emission filter: λem>515 nm; objective: 20X with NA= 0.9. 
 
 
Figure 3.6 Digital fluorescence microscope images of Rhodamine – peptide – QD (λex=460±10nm, 
λem>515nm)with 20X microscope objective by direct attachment of peptide RGDC to QD surface.  
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3.3.2 QD-Mercaptoacetic Acid  
The surface of TOPO coated CdSe/ZnS QDs is hydrophobic; therefore they are not directly 
soluble in aqueous solution. Exchanging the hydrophobic TOPO surfactant molecules with 
bifunctional molecules is the simplest way to obtain a hydrophilic surface. In this way, TOPO 
capped CdSe/ ZnS nanocrystals can be transferred into aqueous solution by exchanging the 
TOPO on their surface with a layer of a mercaptocarbonic acid with thiols (–SH) group as ZnS-
binding groups and carboxyl (–COOH) groups as hydrophilic groups (Fig. 3.7).  Since Carboxyl 
groups on the surface of QDs are negatively charged at neutral pH, QDs capped with carboxyl 
groups repel each other electrostatically, which prevents aggregation. However in electrolyte 
solutions at salt concentrations of a few hundred millimolar, the particles will precipitate due to 
Columbic interactions. 
H
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OH
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Cap exchange
CdSeCdSe S
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Figure3.7 Schematic of synthesis of QD-mercaptocarbonic acids 
 
Based on the work of Nie29, who developed the method ‘cap exchange’ to produce high 
aqueous soluble QDs, suitable for biological applications. The mercaptoacetic aicd was used as a 
bifunctional capping ligand in my study.  The mercapto group in mercaptoacetic acid binds to the 
Zn atom when reacting with CdSe/ZnS QDs and the polar carboxylic acid group renders the QDs 
water – soluble, with the free carboxylic acid can covalently couple to various biomolecules by 
cross – linking to reactive amine groups. 
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Figure 3.8 Digital fluorescence microscope images of QD-mercaptoacetic acid (λex=450nm, λem>515nm) 
in PBS 7.4 buffer with 20X microscope objective  
 
    After the mercaptoacetic acid coated QDs disperse in aqueous solution, the solution appears 
clear under room light. A color luminescence image of QD with mercaptoacetic acid layer is 
shown in Fig 3.8. It indicates that the solubilization steps did not result in a high degree of 
aggregation. Optical measurement showed that the emission spectra in Fig 3.8 are similar for the 
QDs in chloroform and the water – soluble QDs, which demonstrate the optical properties of 
QDs remain nearly unchanged after solubilization (Fig 3.9). The numbers of mercaptoacetic acid 
per QD have not been determined experimentally.  
Unfortunately, the mercaptoacetic acid capped QDs were only stable in aqueous buffer for up 
to one month, after which the QDs precipitated out of solution. The reason for this problem is 
because the thiol–ZnS bonds are dynamic, which means that the thiol ligands bind and unbind in 
a dynamic equilibrium; however, as soon as these nanocrystals are dialyzed against pure buffer 
or water over a longer period, they start to precipitate since all free thiol ligands have 
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disappeared. Therefore the thiol–ZnS bonds are not stable enough to endure a long time, which 
limits the water solubility of CdSe/ZnS QDs capped with mercaptocarbonic acids. Enhanced 
stability can be achieved by using mercaptocarbonic acids with two instead of just one thiol 
group44.  
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 Figure 3.9 Fluorescence emission spectra of the QD before (dash line) and after modification of 
mecaptoacetic acid (solid line) at excitation wavelength of 445 nm 
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3.3.3 Co-coupling Peptide and PEG on QDs 
   In section 3.3.1, the large number of positive residues in the coating peptide molecules may 
have caused aggregation by “bridging” negatively charged QDs. The aggregation problem can be 
overcome by changing peptide RGDC with net positive charge into peptide AGSE with net 
negative charge and by co-coupling peptides and PEG (fig 3.10), a polymer known to minimize 
molecular interactions and improve solubilities57. 
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Figure 3.10 Schematic representations of peptide-coated QDs with PEG 
 
For many years polyethylene glycol (PEG) has been a molecule of interest to the biomedical 
researchers. PEG is a linear neutral polymer available in a variety of molecular weights. It is 
made from the anionic polymerization of ethylene oxide which depending on the polymerization 
conditions forms polymer strands of various lengths. These molecules are soluble in water and 
most organic solvents. The two hydroxyl groups located at each end of the polymer enable it’s 
coupling to peptides, drugs and other biomaterials. PEG coupled to other molecules can alter the 
solubility characteristics of the molecules they are coupled with. This polymer is nontoxic and 
not harmful to the bioactivity of proteins or cells70. PEG has been also used to increase the 
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solubility of formally insoluble drugs and decrease the toxicity of others. PEG has been utilized 
in many research groups as a stabilizer of nanoparticles in aqueous solution.  
In my study, The PEG functionalized with Maleimide (Fig 3.11), which can coat PEG to QDs 
by coupling maleimide of PEG with thiol groups of QDs was obtained from Nektar. As with any 
of thiol PEGylation reagents, use of this PEG-thiol reagent allows thiol-specific PEGylation of 
free thiols forming a disulfide-bridged polymer conjugate to the cysteine side chain of proteins 
and peptides71. This reagent is also useful for thiol groups present in other types of active agents 
and small molecules.  
 
(a) 
 
(b) 
Fig 3.11 Molecular structure of PEG(a) and mPEG-MAL (b) 
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Figure 3.12 Digital fluorescence microscope images of QD-PEG (λex=450nm, λem>515nm) in 10mM 
PBS 7.4 buffer with 20X microscope objective  
 
 
Figure 3.13 Digital fluorescence microscope images of QD after co-coupling of peptide AGSE and PEG 
(λex=450nm, λem>515nm) in 10mM PBS 7.4 buffer with 20X microscope objective  
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Figure 3.14 Emission spectra of (a) QD after co-coupling peptide AGSE and PEG and (b) FRET between 
QD – peptide (PEG) and Rhodamine at excitation wavelength of 445 nm.  
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(a) 
                                                 
                          (b)                                                                                                (c) 
Figure 3.15 Digital fluorescence microscope images of QD with 20X microscope objective 
after co-coupling of peptide AGSE and PEG at (a) 100 mM, (b)50mM and (c)1.5 mM EDAC 
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(a) 
 
 
                                              (b)                                                                                   (c) 
Figure 3.16 Digital fluorescence microscope images with 20X microscope objective of (a) peptide AGSE 
(PEG) coated QDs; (b) Rhodamine-labeled peptide AGSE (PEG) coated QDs at 100ul 4.8 μM 
Rhodamine and (c) (b) Rhodamine-labeled peptide AGSE (PEG) coated QDs at 4.8 μM 200ul Rhodamine. 
 
The presence of both carboxylates and amines on one of the molecules to be conjugated with 
EDAC may also result in self – polymerization, because the substance can then react with 
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another molecule of its own kind instead of the desired target72. In this case, when using EDAC 
to conjugate peptide AGSE to mercaptoacetic acid on the surface of QDs, the peptide contains a 
carboxylate and an amine. The result typically is peptide polymerization and aggregation of QDs. 
Therefore, the test of proper quantity of EDAC should be done to find the ratio of EDAC to 
Peptide AGSE – QDs without precipitation.         
Based on the reasons mentioned above, control of quantity of EDAC was implemented. 
Different concentrations of EDAC for maintaining the stability of QD-peptide AGSE (PEG) 
conjugate from 100 mM to 1.5 mM were tested until a soluble conjugate is obtained. As shown 
in the color luminescence images in Fig 3.15, when scales back the concentration of addition of 
EDAC to 1.5 mM, the problem of precipitation was alleviated significantly. 
After purifying the conjugate by spin dialysis, the Rhodamine, conjugating to peptide AGSE on 
the surface of QDs, was added into the conjugate solution. From the results of the color images 
in Fig 3.16, the emission color of the peptide coated QDs is green (figure 3.16a).  The emission 
color turns yellow when Rhodamine is bound to the peptide coated QDs (figure 3.16b and 3.16c). 
This emission color indicates the FRET between QDs and the bound Rhodamine molecule 
occurs.  
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3.4 Effect of pH on FRET Using Enzymatic Assay 
3.4.1 Effect of PH to the FRET system 
The objective of the experiments described in this section was to determine the effect of pH on 
the FRET efficiency in the QDs – peptide – Rhodamine system. The emission spectra in Fig 3.17 
show the emission intensities of QDs and Rhodamine in FRET system at 545nm and 587 nm 
respectively. The results of indicate that the emission intensities of QDs decreased by ~ 50% 
upon changing the pH 4.0 to pH 9.0. This is important because it demonstrates that pH can affect 
the FRET system between QDs and Rhodamine.  
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 Fig.3.17 Emission Spectra of FRET between QDs and Rhodamin at pH 4.0(a), 7.4(b) and 9.0(c) at 
excitation wavelength of 445 nm. 150μl of 0.1μM peptide coated QDs and 150 μl of 4.6μM Rhodamine 
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Red-X, succinimidyl ester in buffer. 
 
3.4.2 Effect of pH on Enzymatic Activity in QDs-peptide-Rhodamine FRET System 
In our lab, FRET-based enzymatic activity probe was prepared in PBS Buffer 7.4 solution 
containing Rhodamine:QDs at a ratio of 48:1. The tetra-peptide RGDC was used to link between 
the QDs and the Rhodamine molecules. The QDs FRET-based enzymatic probes were first used 
to determine the activity of trypsin. Trypsin is a digestive enzyme that cleaves peptides on the C- 
terminal side of lysine (K) or arginine (R). trypsin would cleave  RGDC peptide to release 
Rhodamine molecules to the solution, which would in turn affect the FRET signal of the QDs.  
In the RGDC particular peptide used in this study the cleavage site was after Arginine (R). 
Enzymes are sensitive to pH and have a specific range of activity. All have an optimum pH. 
The pH can stop enzyme activity by denaturating the three dimensional shape of the enzyme by 
breaking weak bonds such as ionic, and hydrogen bonds. The Optimum pH range of typsin is pH 
8-9. Here the enzymatic activities based on QDs-peptide-Rhodamine FRET system at different 
environments were demonstrated. The emission spectra in fig 3.18 show the effect of trypsin on 
the FRET signal of the Rhodamine-labeled peptide-coated QDs in phosphate buffer solution at 
pH 5.6, 7.4 and 8.7(λex = 445nm).  An increase in the QDs emission peak at 545 nm and a 
decrease in the Rhodamine emission peak at 587 nm are clearly seen, which is attributed to the 
enzymatic cleavage of the peptide molecules which leads to the expected release of Rhodamine 
molecules from the QDs.  It also indicates the optimum pH condition for the enzymatic activity 
in QDs-peptide-Rhodamine FRET system is ~ 9.0 as expected.  
 37 
 
450 500 550 600 650 700
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
Fl
uo
re
sc
en
ce
 In
te
ns
ity
wavelength(nm)
 a before adding trypsin
 b pH=5.64
 c pH=7.44
 d pH=8.70
a
b
c
d
  
Fig 3.18 Fluorescence emission spectra of FRET signal of the Rhodamine-labeled peptide-coated QDs at 
pH 5.64 (b), 7.44(c) and 8.70(c) with and without trypsin(a); 150μl of 0.1 μM peptide coated QDs and 
150 μl of 4.8 μM Rhodamine Red-X, succinimidyl ester in buffer. 
Time dependent measurements of the FRET signal of the QDs at pH 5.6, 7.4 and 8.7 were 
carried out to provide the dynamic information for the enzymatic activity over long observation 
times. Fig 3.19 shows the temporal dependence of the ratio Fa/F0 of the QDs in phosphate buffer 
solution at different pH. Fd is the emission peak of the QDs at 545 nm (donor) and F0 is the 
emission peak of the QDs at 587 nm before adding trypsin. The black square, red round, and blue 
triangle plots are the ratio Fa/F0 of the QDs with time at pH 5.64, 7.4 and 8.7 respectively, which 
indicates the enzymatic activity of trypsin to the system of FRET system over the time of 600 
second. It can be seen that the ratio Fd/F0 increased with time in phosphate buffer solution at 
from pH 5.6 to pH 8.7 and then reached a platform, which indicates typsin was approaching the 
maximal ability of inhibition to FRET system. It was also proved the optimum pH for trypsin in 
this FRET system is pH ~ 9.0 over time, which fits the results expected.  Compared to the old 
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FRET system, which is performed in PBS 7.4 solution, the system in optimum pH 9.0 for trypsin 
can make it affect the FRET system more efficiently.   
In these experiments the emission intensity of the QDs at 545 nm and Rhodamine at 587 nm 
were constantly measured following the addition of trypsin to Rhodamine- labeled peptide-
coated QDs. 
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Figure 3.19 Temporal dependence of the ratio Fa/F0 of the QDs at pH 5.6(a), 7.4 (b) and 8.7(c) at 
excitation wavelength of 445 nm. Fd is the emission peak of the QDs at 545 nm (donor) and F0 is the 
emission peak of the QDs at 587 nm before adding trypsin. 
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CHAPTER 4 SUMMARY 
 
Fluorescence resonance energy is one of a few techniques to measure nanometer scale distance 
and changes in distance based on distance – dependent transfer of energy from a donor 
fluorophore to an acceptor fluorophore. FRET has been recently used in biological applications 
to monitor intracellar interactions and binding events. 
Luminescenct Quantum Dots (QDs) intrigue the interest of researchers with their properties of 
high quantum yield, high molar extinction coefficient, and broad absorption and narrow emission 
spectra. In our laboratory we showed that CdSe/ZnS quantum dots are a visible alterative to 
organic fluorophores in FRET systems.The spectral tunability of QDs improve the spectral 
overlap with an acceptor fluorophore. However, since prepared in organic solvents, QDs are not 
suitable for biological systems. To make QDs with hydrophobic capping ligands to be water – 
soluble, various strategies of the surface functionalization with hydrophilic ligands has been 
developed in recent years.  These strategies are realized primarily by ‘cap exchange’ or 
encapsulation.       
 The ‘cap exchange’ is a process to replace the TOP/TOPO with bifunctional ligands with one 
end binding to the surface of QDs (for example, thiol) and one hydrophilic end group. Typically, 
the group binding to surface is thiol group and hydrophilic group is hydroxyl or carboxyl group.  
This method is simple but is not stable due to the dynamic thiol – ZnS interactions. Although 
dithiol dihydrolipoic acid ligands can improve the stability, almost all carboxyl – terminated 
ligands limit dispersion to basic pHs. In encapsulation methods the TOP/TOPO capped QDs are 
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encapsulated in a heterofunctional polymer coating. The polymer/phospholipids encapsulation 
can work over a broader pH range. However since silica shells tend to increase the diameter of 
CdSe-ZnS from ~ 4-8 nm to ~ 20-30nm, a size that may preclude fluorescence resonance energy 
transfer (FRET)-based investigation. Therefore, ‘cap exchange’ is the predominant method to 
prepare water-soluble QDs in FRET – based biological application.     
In my study, several methods of “cap exchange” were tested to enable forming QDs with 
minimal aggregation.The QD-mercaptoacetic acid is simple to synthesize and has good water-
solubility, but the QDs samples are not stable and easily aggregate after one month in stroage. 
The direct attachment of peptide molecules to the QDs passivate the surface, enable water 
solubility of QDs, and provide a point to biochemical modification. It is only applicable for 
phytochelatin – related peptides, not for all kind of peptides universally; otherwise, the problem 
of aggregation will happen like that in my study with the peptide RGDC.  
The large number of positive residues in the peptide molecules may cause aggregation by 
“bridging” negatively charged QDs. In this study we show that the aggregation problem can be 
overcome by co-coupling peptides and PEG to the QDs. The surfactant-assisted QD-peptide, 
such as Co-coupling net negative charge AGSE and PEG on QDs, has good water –solubility 
when control the quantity of PEG and coupling agent EDAC are properly controlled.  
In the future, further study in this area will focus on optimizing the molecular weight of PEG, 
the ration between peptide and PEG attached to the surface of QDs, functionalization of PEG 
will be optimized.  
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In applying the QDs in biological system, our lab has developed a new QDs based FRET 
probes, in which FRET occurs in a Rhodamin – peptide – QDs system. Since the enzyme trypsin 
is specifically cleave the peptide RGDC between Lysine and Arginine residues. It is possible to 
use the FRET system to measure trypsin activity and other digestive enzymes.  
Enzymes are sensitive to pH and have specific range of activity. All have an optimum pH. The 
pH can stop enzyme activity by denaturating the three dimentional shape of the enzyme by 
breaking weak bonds such as ionic, and hydrogen. For typsin the optimum pH for enzymatic 
activity is 8-9.  
In this study, we tested the effect of pH on FRET system and typsin ability to inhibit in FRET 
between the QDs and Rhodamine. Based on the FRET system using method of direct attachment 
of protein/peptides to QDs surface, the experiments of the effect of pH on FRET were performed. 
We tested the effect of pH 4.0, 7.4 and pH 9.0. The results of emission spectra shown indicate 
pH doesn’t affect significantly the emission intensities of QDs and Rhodamine in FRET system 
at 545nm and 587 nm respectively. This is important because it provides a system that is not 
sensitive to pH.  
The enzymatic activities based on QDs-peptide-Rhodamine FRET system at different 
environments was demonstrated.The results show that pH affect the enzymatic activity more 
significantly. An increase in the QDs emission peak at 545 nm and a decrease in the Rhodamine 
emission peak at 587 nm is clearly seen, which is attributed to the enzymatic cleavage of the 
peptide molecules which leads to the expected release of Rhodamine molecules from the QDs. 
Both emission spectra and time dependent measurements indicate that the optimum pH for the 
trypsin ability of inhibition in this FRET system is pH ~ 9.0, which fits the results expected.   
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For the effect of pH to the enzymatic activity of the QDs based FRET probe, the mechanism of 
it can be studied in detail  in the future  to help understand fully this quantum dots based FRET 
system. The inhibitor of trypsin can be used to test the effect of inhibitor of trypsin on the 
enzymatic activity in QDs FRET system, which can be used in biological system if well explored.  
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